Myricetin relieves LPS-induced mastitis by inhibiting inflammatory response and repairing the blood-milk barrier
Myricetin relieves LPS-induced mastitis by inhibiting inflammatory response and repairing the blood-milk barrier
复制标题
杨梅素通过抑制炎症反应和修复血乳屏障缓解脂多糖引起的乳腺炎
DOI:
10.1002/jcp.28288
复制
发表时间:
2019-09-01
影响因子:
5.6
通讯作者:
Liu, Juxiong
中科院分区:
文献类型:
--
作者:
Kan, Xingchi;Liu, Bingrun;Liu, Juxiong
Mastitis, an inflammation of mammary gland, is a serious disease that affects the health of dairy cows around the world. Myricetin, a flavonoid from Bayberry, has been reported to suppress various inflammatory response. The aim of this study was to evaluate the effect of myricetin on lipopolysaccharide (LPS)-induced in vivo and in vitro mastitis model and clarify the underlying mechanism. In vivo experiments, myricetin attenuated the severity of inflammatory lesion and neutrophil infiltration. Moreover, myricetin pretreatment induced a significant decrease in the activity of myeloperoxidase (MPO) and the production of TNF-, IL-6, and IL-1 triggered by LPS. Myricetin pretreatment could also increase the integrity of the blood-milk barrier and upregulate the tight junction proteins in LPS-induced mice mastitis. In vitro, myricetin inhibited LPS-induced inflammatory response in mice mammary epithelial cells (mMECs). In the further mechanism studies, we found that the anti-inflammatory effect of myricetin was mediated by inhibiting LPS-induced phosphorylation of AKT, IKK-, IB-, and P65 in vivo and in vitro. Collectively, these data suggested that myricetin effectively ameliorated the inflammatory response by inhibiting the AKT/IKK/NF-B signaling pathway and repairing the integrity of blood-milk barrier in LPS-induced mice mastitis.